Aldosterone Blockade: Current and Potential Future Cardiovascular Indications
Einstein-Montefiore Department of Medicine Grand Rounds
Thursday, December 4, 2008
First Floor Lecture Hall, Forchheimer/Einstein
Cherkasky Auditorium/Montefiore Medical Center
Bertram Pitt, MD
Professor of Medicine Emeritus
Chief of Cardiology Emeritus
University of Michigan School of Medicine
A Special Medical Grand Rounds this week is sponsored by the Division of Cardiology and will be presented by Dr. Bertram Pitt of the University of Michigan.
Dr. Pitt is one of Cardiology's leading clinical researchers, having been the principal or co-principal investigator of many of the most important randomized clinical pharmacologic trials. Based upon basic science knowledge of aldosterone's potential for myocardial damage, Dr. Pitt played key roles in designing and leading international trials in myocardial infarction and congestive heart failure, demonstrating protection by aldosterone inhibitors. He is currently leading several multicenter investigations of novel medications in other cardiomyopathic conditions.
Dr. Pitt has held major leadership positions in the American College of Cardiology and the American Heart Association. He has co-authored over 500 peer-reviewed papers, and has received numerous honors, including The James B. Herrick award, one of the highest awards of the American Heart Association. His honorary societies include The American Society for Clinical Research, the Association of American Physicians, and Association of University Cardiologists.
Dr. Pitt's presentation will include not only the current indications for aldosterone inhibition in cardiology, but also the translation of mechanisms discovered in the laboratory to large multicenter clinical trials and the use of these concepts in considerations for future clinical research.
This Grand Rounds is supported by a fund set up by Montefiore in honor of Dr. James Scheuer, University Chairman of Medicine Emeritus, and we are deeply grateful to Dr. Scheuer for his support.
After attending this activity, participants will be able to:
- Understand the current cardiovascular indications for aldosterone blockade
- Understand the potential mechanisms for the beneficial effects of aldosterone blockade
- Understand the opportunities for further clinical research and use of aldosterone blockade in patients with cardiovascular disease
Albert Einstein College of Medicine designates this educational activity for a maximum of 1 credit towards the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity.
Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.